# Jently reviews (2026): GLP-1 telehealth sellers | This GLP

A New York telehealth platform that names its compounding pharmacy and opens on a no-commitment month.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/jently
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Named pharmacy, month to month

# Jently review

A New York telehealth platform that names its compounding pharmacy and opens on a no-commitment month.

## The verdict

Jently sells compounded semaglutide at $199 and compounded tirzepatide at $259 for a single month, the tab each product page opens on, and it names the pharmacy that makes both. The lower figures on its homepage belong to prepaid terms, and a reader who plans a year from those cards will be planning around a lump-sum commitment rather than a monthly bill.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

From

From $199/mo

Dose published

No

Prescription

Required

Compounded

Yes — not FDA-approved

Pharmacy

Named

Jently is a New York-based telehealth platform whose shelf runs from compounded semaglutide and tirzepatide injections to NAD+, sermorelin, glutathione and metformin. It describes itself as a platform that arranges clinical evaluations rather than a pharmacy or a manufacturer, and every weight-management page carries the same disclosure about who makes the medication.

1.  ## Who writes the prescription, and what do they see?
    
    Clinical care runs through a partnership with MD Integrations and its network of licensed providers, and the page says every clinician is a licensed physician practicing within the patient's state. A provider reviews the intake and decides whether any prescription is written at all; the page is careful to say that completing the assessment does not guarantee medication. No individual physician is named.
    
    The path is an online intake, a provider review, a prescription decision and then shipment from the pharmacy, with follow-up support described as ongoing so a provider can adjust treatment. Card details are collected during the questionnaire, but the refund policy says payment is taken only after a provider approves. A subscription can be paused for up to sixty days without penalty, and lost or damaged shipments are reshipped at no charge.
    
2.  ## What happens when the dose goes up?
    
    Neither product page prints a dose or says whether the monthly figure changes as the dose climbs, so a patient moving up the ladder in month three cannot tell from the page whether the $199 still holds. The page says only that the provider sets an individualized plan and adjusts it during follow-up. That leaves the costliest question of the first four months unanswered in writing, and it is the one worth asking before the first fill.
    
3.  ## What the price includes
    
    Each product page offers four tabs, one, three, six and twelve months, and opens on the single month, billed as a one-time purchase with free cold-chain shipping. The three prepaid tabs are labeled as a founding-member price lock and are each charged as one lump sum. A consultation fee is stated as included in the monthly figure. Three single months of semaglutide come to $597, and six months of tirzepatide to $1,554.
    
4.  ## What it claims, and what it cites
    
    Both lines are compounded by Precision Compounding Pharmacy in Bellmore, New York, which the page describes as a state-licensed 503A pharmacy. Jently states that compounded drugs are not FDA-approved and that the FDA does not review them for safety, effectiveness or quality.
    

## Where it holds up, and where it does not

-   Strength: The compounding pharmacy is named with its address
-   Strength: Opens on a no-commitment single month
-   Strength: Payment taken only after provider approval
-   Strength: Subscriptions can pause for sixty days
-   Limitation: No dose is printed on either page
-   Limitation: Dose-step pricing is not stated
-   Limitation: Homepage cards show the twelve-month equivalent
-   Limitation: No refund once a consultation is completed

## What the evidence says about this kind of treatment

The assessment above is about Jently. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A patient who wants to know which pharmacy compounds the medication before paying for it.

Wrong for

A buyer who needs the price at each dose step written down in advance.

## The evidence behind what Jently prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How Jently compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| Piper | Buyers who want the compounding pharmacy named before they hand over a card |  |
| Liberty | A reader who wants to know what kind of facility made the vial, and will accept a mid-market rate to get that in writing. |  |
| Cielo | Buyers who want the commitment behind a headline rate spelled out in the asterisk under it |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Invigor Medical](https://thisglp.com/reviews/invigor-medical) [Invyncible](https://thisglp.com/reviews/invyncible) [Iron Med RX](https://thisglp.com/reviews/iron-med-rx) [iThriveMD](https://thisglp.com/reviews/ithrivemd) [Ivim Health](https://thisglp.com/reviews/ivim-health) [Ivologist](https://thisglp.com/reviews/ivologist)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

Why does the homepage show a lower price?

The homepage cards quote the twelve-month prepaid rung. The single-month tab each product page opens on is $199 for semaglutide and $259 for tirzepatide.

Who makes the medication?

Precision Compounding Pharmacy in Bellmore, New York, which the page describes as a state-licensed 503A compounding pharmacy.

Can I get a refund?

Only before a consultation is completed or a prescription is dispensed, and the request must be made within 24 hours of the order.

Is Jently expensive compared with other GLP-1 telehealth sellers?

Jently publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Jently above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
